These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 3288167)

  • 1. Targeting of cancer with radiolabeled antibodies. Prospects for imaging and therapy.
    Goldenberg DM
    Arch Pathol Lab Med; 1988 Jun; 112(6):580-7. PubMed ID: 3288167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinoembryonic antigen as a target cancer antigen for radiolabeled antibodies: prospects for cancer imaging and therapy.
    Goldenberg DM
    Tumour Biol; 1995; 16(1):62-73. PubMed ID: 7863224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical studies of cancer radioimmunodetection with carcinoembryonic antigen monoclonal antibody fragments labeled with 123I or 99mTc.
    Goldenberg DM; Goldenberg H; Sharkey RM; Higginbotham-Ford E; Lee RE; Swayne LC; Burger KA; Tsai D; Horowitz JA; Hall TC
    Cancer Res; 1990 Feb; 50(3 Suppl):909s-921s. PubMed ID: 2297741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and treatment of neoplasms with radionuclide-labeled antibodies.
    DeLand FH; Goldenberg DM
    Semin Nucl Med; 1985 Jan; 15(1):2-11. PubMed ID: 2580353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological and clinical perspectives of cancer imaging and therapy with radiolabeled antibodies.
    Goldenberg DM; Blumenthal RD; Sharkey RM
    Semin Cancer Biol; 1990 Jun; 1(3):217-25. PubMed ID: 2103497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of cancer immunodetection with radiolabeled human monoclonal antibodies.
    De Jager R; Abdel-Nabi H; Serafini A; Pecking A; Klein JL; Hanna MG
    Semin Nucl Med; 1993 Apr; 23(2):165-79. PubMed ID: 8511602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer imaging with radiolabeled antibodies: new advances with technetium-99m-labeled monoclonal antibody Fab' fragments, especially CEA-Scan and prospects for therapy.
    Goldenberg DM; Juweid M; Dunn RM; Sharkey RM
    J Nucl Med Technol; 1997 Mar; 25(1):18-23; quiz 34. PubMed ID: 9239599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status of cancer imaging with radiolabeled antibodies.
    Goldenberg DM
    J Cancer Res Clin Oncol; 1987; 113(3):203-8. PubMed ID: 3294845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Future role of radiolabeled monoclonal antibodies in oncological diagnosis and therapy.
    Goldenberg DM
    Semin Nucl Med; 1989 Oct; 19(4):332-9. PubMed ID: 2678484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiolabeled monoclonal anti-tumor antibodies in diagnosis and therapy.
    Larson SM
    J Nucl Med; 1985 May; 26(5):538-45. PubMed ID: 3989608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging and therapy of gastrointestinal cancers with radiolabeled antibodies.
    Goldenberg DM
    Am J Gastroenterol; 1991 Oct; 86(10):1392-403. PubMed ID: 1656726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioimmunodetection of cancer with the use of indium-111-labeled monoclonal antibodies.
    Dillman RO; Beauregard J; Ryan KP; Hagan PL; Clutter M; Amox D; Frincke JM; Bartholomew RM; Burnett KG; David GS
    NCI Monogr; 1987; (3):33-6. PubMed ID: 3821917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological considerations in the use of goat antibodies to carcinoembryonic antigen for the radioimmunodetection of cancer.
    Primus FJ; Goldenberg DM
    Cancer Res; 1980 Aug; 40(8 Pt 2):2979-83. PubMed ID: 6772299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging of colorectal carcinoma with radiolabeled antibodies.
    Goldenberg DM; Goldenberg H; Sharkey RM; Lee RE; Higgenbotham-Ford E; Horowitz JA; Hall TC; Pinsky CM; Hansen HJ
    Semin Nucl Med; 1989 Oct; 19(4):262-81. PubMed ID: 2678479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretargeting with labeled bivalent peptides allowing the use of four radionuclides: (111)In, (131)I, (99m)Tc, and (188)Re.
    van Schaijk FG; Oosterwijk E; Soede AC; Oyen WJ; McBride WJ; Griffiths GL; Goldenberg DM; Corstens FH; Boerman OC
    Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3880S-5S. PubMed ID: 14506186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of indium-111-labeled chimeric anti-CEA monoclonal antibody.
    Wong JY; Thomas GE; Yamauchi D; Williams LE; Odom-Maryon TL; Liu A; Esteban JM; Neumaier M; Dresse S; Wu AM; Primus FJ; Shively JE; Raubitschek AA
    J Nucl Med; 1997 Dec; 38(12):1951-9. PubMed ID: 9430476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical radioimmunodetection, 1978-1988: overview and suggestions for standardization of clinical trials.
    Larson SM
    Cancer Res; 1990 Feb; 50(3 Suppl):892s-898s. PubMed ID: 2404583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor localization using radiolabeled monoclonal antibodies. An overview.
    Zalcberg JR
    Am J Clin Oncol; 1985 Dec; 8(6):481-9. PubMed ID: 3909809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BIS-1: a novel bispecific monoclonal antibody for CEA-expressing carcinoma radioimmunoscintigraphy and radioimmunotherapy.
    Parisi A; Bartolazzi A; Bonino C; Camagna M; DeMonte LB; Lombardi A; Natali PG; Paganelli G; Tarditi L; Vassarotto C
    Year Immunol; 1993; 7():96-105. PubMed ID: 8372516
    [No Abstract]   [Full Text] [Related]  

  • 20. Radioimmunodetection of cancer with radioactive antibodies to carcinoembryonic antigen.
    Goldenberg DM; Kim EE; DeLand FH; Bennett S; Primus FJ
    Cancer Res; 1980 Aug; 40(8 Pt 2):2984-92. PubMed ID: 7397693
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.